Dr. Laurie K. Pearson, MD

Dr. Pearson practices at Umass Memorial Medical Center in Mendon, Massachusetts.

Dr. Pearson's NPI, 1285013078, was assigned on May 26, 2015. Dr. Pearson graduated from Wake Forest University School of Medicine in 2015. Dr. Pearson holds Massachusetts license 274035.

Dr. Pearson's primary practice is Umass Memorial Medical Center, at 55 North Ave, Mendon, MA 01756 in Worcester County. The practice phone is (508) 334-1000.

Dr. Pearson's primary practice is Umass Memorial Medical Center in Mendon, Massachusetts. Dr. Pearson is also affiliated with UMass Memorial Medical Center - University Campus. The medical group on file is UMass Memorial Medical Group. Dmand AI also links Dr. Pearson to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pearson practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Pearson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Pearson is licensed in Massachusetts.

CMS data shows 506 Medicare services from Dr. Pearson across 10 procedure codes in 2024, for 158 Medicare patients. Medicare paid $36,080 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 158 Medicare patients who saw Dr. Pearson in 2024. The largest group is 65 to 74, with 63 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 33% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pearson's median patient age at 73, with 48% women.

In 2024, Dr. Pearson wrote 685 Medicare Part D claims for 63 patients. 77% of them were for generic drugs. CMS names the drug for 432 of them, across 17 drugs with 11 or more claims each, at $1,281,960 in total drug cost. In 2023, CMS named 57 claims across 3 drugs.

Dr. Pearson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pearson as offering telehealth.

Dmand AI links 6 papers to Dr. Pearson, published from 2019 to 2024. 2019 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Bridged Bicyclo Compounds, Heterocyclic and Leukemia, Lymphocytic, Chronic, B-Cell. Dr. Pearson's most frequent co-authors are Paul Michael Barr, MD, Catherine C. Coombs, MD and Nicole Lamanna, MD.

CMS Open Payments shows 10 general payments to Dr. Pearson from 5 drug and device companies in 2025. Consulting fees make up the largest share, 91% of the total. Janssen Research & Development, LLC paid the most, $2,940.

Dr. Pearson graduated from Wake Forest University School of Medicine in 2015.